Abstract
Major pulmonary embolism occurring insidiously over several weeks (subacute massive pulmonary embolism) has a high mortality and may not respond well to standard anticoagulant or thrombolytic treatment. A priming dose of plasminogen was used to enhance thrombolysis produced by a streptokinase infusion in five consecutive patients with subacute massive pulmonary embolism. In each patient a dramatic clinical improvement occurred with a substantial increase in pulmonary blood flow. All five patients survived to leave hospital. Malignant disease was the underlying cause of embolism in three patients, two of whom died of their malignant disease in the six months after treatment of their pulmonary embolism. The third patient with malignant disease had a choriocarcinoma; at least some of the pulmonary obstruction may have been tumour tissue but this obstruction was dramatically cleared by the treatment. The use of a combination of plasminogen with streptokinase should be considered in severely ill patients with subacute massive pulmonary embolism, particularly if other treatment, including streptokinase alone, has failed.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Griguer P., Charbonnier B., Latour F., Fauchier J. P., Brochier M. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism. Angiology. 1979 Jan;30(1):1–12. doi: 10.1177/000331977903000101. [DOI] [PubMed] [Google Scholar]
- Hall R. J., McHaffie D., Pusey C., Sutton G. C. Subacute massive pulmonary embolism. Br Heart J. 1981 Jun;45(6):681–688. doi: 10.1136/hrt.45.6.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kakkar V. V., Sagar S., Lewis M. Treatment of deep-vein thrombosis with intermittent streptokinase and plasminogen infusion. Lancet. 1975 Oct 11;2(7937):674–676. doi: 10.1016/s0140-6736(75)90774-6. [DOI] [PubMed] [Google Scholar]
- Miller G. A., Sutton G. C., Kerr I. H., Gibson R. V., Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J. 1971 Jun 19;2(5763):681–684. doi: 10.1136/bmj.2.5763.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogston D., Ogston C. M., Fullerton H. W. The plasminogen content of thrombi. Thromb Diath Haemorrh. 1966 Jan 31;15(1):220–230. [PubMed] [Google Scholar]
- Sutton G. C., Hall R. J., Kerr I. H. Clinical course and late prognosis of treated subacute massive, acute minor, and chronic pulmonary thromboembolism. Br Heart J. 1977 Oct;39(10):1135–1142. doi: 10.1136/hrt.39.10.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thorsen S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids. Biochim Biophys Acta. 1975 May 30;393(1):55–65. doi: 10.1016/0005-2795(75)90216-0. [DOI] [PubMed] [Google Scholar]